Light Mode
$18.91 ↑ +0.00 (+0.00%) Trading Up from the previous close of $18.91, $0.91 below the day’s high of $19.83
-11.79 (-38.40%) / 6M
Momentum, market sentiment, and recent alerts
PRPO reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -9.3%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
Precipio, Inc.is a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. It operates through the following business divisions: Pathology Services and Products. The Pathology Services division provides specialized cancer diagnostic testing services to physicians, hospitals, and laboratories. The Products divisions develops and commercializes proprietary assays designed for use by clinical laboratories. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.